Cargando…
1235. Roles of Tetracyclines for Treatment of Stenotrophomonas maltophilia Pneumonia
BACKGROUND: Stenotrophomonas maltophilia is a multidrug resistant organism with limited antibiotic treatment options. Sulfamethoxazole-trimethoprim (TMP-SMZ) is considered first line agent based on in vitro studies and clinical evidence. Minocycline has been showed to be active on in vitro studies a...
Autores principales: | Alhayani, Taha, Philpott, Carolyn, Liao, Siyun, Gentene, Anthony, Mueller, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644570/ http://dx.doi.org/10.1093/ofid/ofab466.1427 |
Ejemplares similares
-
1585. Stenotrophomonas maltophilia Infections and Approaches to Treatment
por: Caffrey, Aisling, et al.
Publicado: (2020) -
1491. Standard- vs. High-dose Trimethoprim-Sulfamethoxazole for Stenotrophomonas maltophilia pneumonia
por: Hall, Brenton C, et al.
Publicado: (2020) -
1065. Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits
por: Petraitis, Vidmantas, et al.
Publicado: (2021) -
1600. Closing the gap on moxifloxacin breakpoints for Stenotrophomonas maltophilia
por: Stone, Tyler J, et al.
Publicado: (2020) -
847. Trends in Stenotrophomonas maltophilia Antibiotic Resistance Rates
por: Caffrey, Aisling, et al.
Publicado: (2020)